208 related articles for article (PubMed ID: 27454593)
1. Endolymphatic Sac Tumor Showing Increased Activity on 68Ga DOTATATE PET/CT.
Papadakis GZ; Millo C; Sadowski SM; Bagci U; Patronas NJ
Clin Nucl Med; 2016 Oct; 41(10):783-4. PubMed ID: 27454593
[TBL] [Abstract][Full Text] [Related]
2. Endolymphatic sac tumors. A source of morbid hearing loss in von Hippel-Lindau disease.
Manski TJ; Heffner DK; Glenn GM; Patronas NJ; Pikus AT; Katz D; Lebovics R; Sledjeski K; Choyke PL; Zbar B; Linehan WM; Oldfield EH
JAMA; 1997 May; 277(18):1461-6. PubMed ID: 9145719
[TBL] [Abstract][Full Text] [Related]
3. Epididymal Cystadenomas in von Hippel-Lindau Disease Showing Increased Activity on 68Ga DOTATATE PET/CT.
Papadakis GZ; Millo C; Sadowski SM; Bagci U; Patronas NJ
Clin Nucl Med; 2016 Oct; 41(10):781-2. PubMed ID: 27454594
[TBL] [Abstract][Full Text] [Related]
4. Characterization of endolymphatic sac tumors and von Hippel-Lindau disease in the International Endolymphatic Sac Tumor Registry.
Bausch B; Wellner U; Peyre M; Boedeker CC; Hes FJ; Anglani M; de Campos JM; Kanno H; Maher ER; Krauss T; Sansó G; Barontini M; Letizia C; Hader C; Schiavi F; Zanoletti E; Suárez C; Offergeld C; Malinoc A; Zschiedrich S; Glasker S; Bobin S; Sterkers O; Ba Huy PT; Giraud S; Links T; Eng C; Opocher G; Richard S; Neumann HP;
Head Neck; 2016 Apr; 38 Suppl 1():E673-9. PubMed ID: 25867206
[TBL] [Abstract][Full Text] [Related]
5. 68Ga-DOTATATE Uptake in an Endolymphatic Sac Tumor: Radiologic-Pathologic Correlation.
Lou R; Lazor JW; Baraban E; Ware JB; Cooper K; Pantel AR
Clin Nucl Med; 2020 Jul; 45(7):563-565. PubMed ID: 32433163
[TBL] [Abstract][Full Text] [Related]
6. 18F-FDG and 68Ga-DOTATATE PET/CT in von Hippel-Lindau Disease-Associated Retinal Hemangioblastoma.
Papadakis GZ; Millo C; Jassel IS; Bagci U; Sadowski SM; Karantanas AH; Patronas NJ
Clin Nucl Med; 2017 Mar; 42(3):189-190. PubMed ID: 28033220
[TBL] [Abstract][Full Text] [Related]
7. Kidney Tumor in a von Hippel-Lindau (VHL) Patient With Intensely Increased Activity on 68Ga-DOTA-TATE PET/CT.
Papadakis GZ; Millo C; Sadowski SM; Bagci U; Patronas NJ
Clin Nucl Med; 2016 Dec; 41(12):970-971. PubMed ID: 27749408
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterisation of sporadic endolymphatic sac tumours and comparison to von Hippel-Lindau disease-related tumours.
Schweizer L; Thierfelder F; Thomas C; Soschinski P; Kim HY; Jödicke R; Woltering N; Förster A; Teichmann D; Siewert C; Klein K; Schmid S; Nunninger M; Thomale UW; Onken J; Mühleisen H; Schittenhelm J; Tatagiba M; von Deimling A; Reuss DE; Solomon DA; Heppner FL; Koch A; Hartmann C; Staszewski O; Capper D
Neuropathol Appl Neurobiol; 2021 Oct; 47(6):756-767. PubMed ID: 34091929
[TBL] [Abstract][Full Text] [Related]
9. Differential grading of endolymphatic sac tumor extension by virtue of von Hippel-Lindau disease status.
Bambakidis NC; Megerian CA; Ratcheson RA
Otol Neurotol; 2004 Sep; 25(5):773-81. PubMed ID: 15354010
[TBL] [Abstract][Full Text] [Related]
10. The vestibular aqueduct: site of origin of endolymphatic sac tumors.
Lonser RR; Baggenstos M; Kim HJ; Butman JA; Vortmeyer AO
J Neurosurg; 2008 Apr; 108(4):751-6. PubMed ID: 18377255
[TBL] [Abstract][Full Text] [Related]
11. Endolymphatic sac tumor with von Hippel-Lindau disease: report of a case with atypical pathology of endolymphatic sac tumor.
Yang X; Liu XS; Fang Y; Zhang XH; Zhang YK
Int J Clin Exp Pathol; 2014; 7(5):2609-14. PubMed ID: 24966975
[TBL] [Abstract][Full Text] [Related]
12. Effects of VHL deficiency on endolymphatic duct and sac.
Gläsker S; Lonser RR; Tran MG; Ikejiri B; Butman JA; Zeng W; Maxwell PH; Zhuang Z; Oldfield EH; Vortmeyer AO
Cancer Res; 2005 Dec; 65(23):10847-53. PubMed ID: 16322231
[TBL] [Abstract][Full Text] [Related]
13. The utility of
Shell J; Tirosh A; Millo C; Sadowski SM; Assadipour Y; Green P; Patel D; Nilubol N; Kebebew E
Eur J Radiol; 2019 Mar; 112():130-135. PubMed ID: 30777201
[TBL] [Abstract][Full Text] [Related]
14. Imaging detection of endolymphatic sac tumor-associated hydrops.
Butman JA; Nduom E; Kim HJ; Lonser RR
J Neurosurg; 2013 Aug; 119(2):406-11. PubMed ID: 23472846
[TBL] [Abstract][Full Text] [Related]
15. Expression of renal cell markers and detection of 3p loss links endolymphatic sac tumor to renal cell carcinoma and warrants careful evaluation to avoid diagnostic pitfalls.
Jester R; Znoyko I; Garnovskaya M; Rozier JN; Kegl R; Patel S; Tran T; Abedalthagafi M; Horbinski CM; Richardson M; Wolff DJ; Lapadat R; Moore W; Rodriguez FJ; Mull J; Olar A
Acta Neuropathol Commun; 2018 Oct; 6(1):107. PubMed ID: 30340515
[TBL] [Abstract][Full Text] [Related]
16. Endolymphatic sac tumor in von Hippel-Lindau disease.
Williamson RA; Coker NJ
Otol Neurotol; 2003 Sep; 24(5):832. PubMed ID: 14501465
[No Abstract] [Full Text] [Related]
17. Management of endolymphatic sac tumors: sporadic cases and von Hippel-Lindau disease.
Nevoux J; Nowak C; Vellin JF; Lepajolec C; Sterkers O; Richard S; Bobin S
Otol Neurotol; 2014 Jun; 35(5):899-904. PubMed ID: 24662627
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of morbid hearing loss associated with tumors of the endolymphatic sac in von Hippel-Lindau disease.
Butman JA; Kim HJ; Baggenstos M; Ammerman JM; Dambrosia J; Patsalides A; Patronas NJ; Oldfield EH; Lonser RR
JAMA; 2007 Jul; 298(1):41-8. PubMed ID: 17609489
[TBL] [Abstract][Full Text] [Related]
19. [Adenocarcinoma of the endolymphatic sac in von Hippel-Lindau disease. A case report].
Martínez-Miravete P; Domínguez P; Zubieta JL; Manrique M
Radiologia; 2007; 49(4):287-9. PubMed ID: 17594893
[TBL] [Abstract][Full Text] [Related]
20. [Endolymphatic sac tumor with von Hippel-Lindau disease: report of two cases with testing of von Hippel-Lindau gene].
Su Y; Shen WD; Wang CC; Han WJ; Liu J; Hou ZH; Song ZG; Huang DL; Han DY; Yang SM
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Nov; 48(11):913-8. PubMed ID: 24444636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
